Neuromod Closes €10 Million Financing to Accelerate Commercialization of Lenire
Neuromod Devices Ltd. has secured €10 million in oversubscribed equity financing to expand the availability of its FDA-approved tinnitus treatment device, Lenire.
Neuromod Devices Ltd. has secured €10 million in oversubscribed equity financing to expand the availability of its FDA-approved tinnitus treatment device, Lenire.
Specialist tinnitus service, Ótologie Tinnitus Care is offering free assessments to people living with tinnitus to mark its sponsorship of the British Tinnitus Association’s Tinnitus Week, which runs from February 7-13, 2022.Â